Cytokines in inflammatory bowel diseases - Update 2020
- PMID: 32416212
- DOI: 10.1016/j.phrs.2020.104835
Cytokines in inflammatory bowel diseases - Update 2020
Abstract
Inflammatory Bowel Diseases (IBD), namely Crohn's Disease and Ulcerative Colitis, cause a significant disease burden in modern civilization. Ever since the introduction of anti-TNF-directed therapies 20 years ago, cytokines have attracted a lot of research attention and several cytokine-directed therapies have been implemented in the clinical treatment of these diseases. The research progress in these past years has underlined the importance of both myeloid and lymphoid elements of the immune system in the pathogenesis of IBD and their cytokine-mediated interplay. The conceptual framework of the mucosal cytokine network has shifted during these years from a T helper (Th) dichotomy (Th1/Th2) to the effector/regulatory T cell balance, while nowadays, the importance of myeloid cell instruction of lymphocytes, namely by IL-12 and IL-23, is increasingly recognized. Anti-IL-12p40 agents, like ustekinumab, groundbreakingly changed patient care, and anti-IL23p19-directed approaches are on the verge of grand success. In this review we present a modular approach to understand the cytokine network and put it into the context of the pathogenesis of IBD with a special focus on publications since 2014.
Keywords: Biologicals; Crohn’s disease; Cytokines; Gastroenterology; IBD; Ulcerative colitis.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest M.L. has no conflict of interest to report.
Similar articles
-
Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.Curr Mol Pharmacol. 2008 Nov;1(3):195-212. doi: 10.2174/1874467210801030195. Curr Mol Pharmacol. 2008. PMID: 20021434 Review.
-
Inflammatory Bowel Disease Drugs: A Focus on Autophagy.J Crohns Colitis. 2017 Jan;11(1):118-127. doi: 10.1093/ecco-jcc/jjw127. Epub 2016 Jul 5. J Crohns Colitis. 2017. PMID: 27381462 Free PMC article. Review.
-
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. BioDrugs. 2010. PMID: 21175228 Review.
-
Biologic therapy for inflammatory bowel disease.Drugs. 2005;65(16):2253-86. doi: 10.2165/00003495-200565160-00002. Drugs. 2005. PMID: 16266194 Review.
-
Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.Curr Opin Gastroenterol. 2009 Jul;25(4):306-13. doi: 10.1097/MOG.0b013e32832bc627. Curr Opin Gastroenterol. 2009. PMID: 19448533 Review.
Cited by
-
The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD.Front Immunol. 2022 Nov 18;13:1028953. doi: 10.3389/fimmu.2022.1028953. eCollection 2022. Front Immunol. 2022. PMID: 36466902 Free PMC article. Review.
-
The significance of long non-coding RNAs in the pathogenesis, diagnosis and treatment of inflammatory bowel disease.Precis Clin Med. 2023 Dec 11;6(4):pbad031. doi: 10.1093/pcmedi/pbad031. eCollection 2023 Dec. Precis Clin Med. 2023. PMID: 38163004 Free PMC article. Review.
-
Isosteviol Sodium Exerts Anti-Colitic Effects on BALB/c Mice with Dextran Sodium Sulfate-Induced Colitis Through Metabolic Reprogramming and Immune Response Modulation.J Inflamm Res. 2021 Dec 20;14:7107-7130. doi: 10.2147/JIR.S344990. eCollection 2021. J Inflamm Res. 2021. PMID: 34992409 Free PMC article.
-
Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases.Inflamm Bowel Dis. 2021 Nov 15;27(Suppl 2):S1-S16. doi: 10.1093/ibd/izab230. Inflamm Bowel Dis. 2021. PMID: 34791292 Free PMC article.
-
Butyrate Alleviates Cytokine-Induced Barrier Dysfunction by Modifying Claudin-2 Levels.Biology (Basel). 2021 Mar 9;10(3):205. doi: 10.3390/biology10030205. Biology (Basel). 2021. PMID: 33803334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
